Medobar refers to Dobasic Hydrazide Tablets. Dobasic Hydrazide Tablets are anti-Parkinson’s disease medications used to treat Parkinson’s, symptomatic Parkinson’s syndrome, but not for Parkinson’s syndrome caused by drug stimulation. Adverse effects of Dobasic Hydrazide Tablets include anxiety, insomnia, nausea, vomiting, and diarrhea. Contraindications of Dobas Hydrazide Tablets include contraindications in patients with hypersensitivity to levodopa, benserazide, or their excipients; this product is contraindicated for use in combination with non-selective monoamine oxidase inhibitors; this product is contraindicated in patients younger than 25 years of age, and so on. If you need to treat the disease by Dobasic Hydrazide Tablets, you need to combine with the specific disease, under the guidance of the doctor to use the drug, not private medication.